Ricasetron

Ricasetron (BRL-46470) is a selective and orally active 5-HT3 receptor antagonist. Ricasetron displays little or no affinity for a variety of other neurotransmitter receptors. Ricasetron has anxiolytic and antiemetic effects[1][2].

Product Specifications

CAS Number

[117086-68-7]

Product Name Alternative

BRL-46470

UNSPSC

12352005

Target

5-HT Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/ricasetron.html

Purity

98.62

Solubility

DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

O=C(N1C(C=CC=C2)=C2C(C)(C)C1)N[C@H]3C[C@@H](CC4)N(C)[C@@H]4C3

Molecular Formula

C19H27N3O

Molecular Weight

313.44

References & Citations

[1]Steward LJ, et al. Evidence that the atypical 5-HT3 receptor ligand, [3H]-BRL46470, labels additional 5-HT3 binding sites compared to [3H]-granisetron. Br J Pharmacol. 1995 Sep;116 (2) :1781-8.|[2]Gao B, et al. Effects of sub-chronic treatment with chlordiazepoxide, buspirone and the 5-HT3 receptor antagonist, BRL 46470, on the social behaviour of mice. Neuropharmacology. 1992 Mar;31 (3) :207-13.